Literature DB >> 3220708

Beneficial effect of botulinum A toxin in blepharospasm: 16 months' experience with 16 cases.

S Maurri1, S Brogelli, G Alfieri, F Barontini.   

Abstract

After introducing the problem of blepharospasm, we report our experience on treatment with purified botulinum A toxin in 16 cases of blepharospasm, symptomatic in two and essential in 14, than had not responded to drugs. The changes in intensity and frequency of spasm after treatment were evaluated on a clinical scale and by review of videotapes. The beneficial effect appeared within a week in most patients, lasting from 6 to 28 weeks (mean 13), and reached the maximum at the third-seventh week. Mild spasms and female patients responded better. Repeated injections were followed by better response to the drug. Complications, exclusively local, were represented by transient corneal exposure, ptosis, lacrimation or diplopia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3220708     DOI: 10.1007/bf02333996

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  28 in total

1.  Botulinum toxin in the management of blepharospasm.

Authors:  J J Dutton; E G Buckley
Journal:  Arch Neurol       Date:  1986-04

2.  The use of botulinum toxin in the medical management of benign essential blepharospasm.

Authors:  K I Perman; H I Baylis; A L Rosenbaum; D G Kirschen
Journal:  Ophthalmology       Date:  1986-01       Impact factor: 12.079

3.  Pharmacology of cranial dystonia.

Authors:  C D Marsden; A E Lang; M P Sheehy
Journal:  Neurology       Date:  1983-08       Impact factor: 9.910

4.  Apraxia of lid opening.

Authors:  A Brusa; S Meneghini; A Piccardo; R Stoehr
Journal:  Ital J Neurol Sci       Date:  1981-12

5.  Effectiveness of botulinum toxin therapy for essential blepharospasm.

Authors:  P F Engstrom; J B Arnoult; M L Mazow; T C Prager; R B Wilkins; W A Byrd; R J Hofmann
Journal:  Ophthalmology       Date:  1987-08       Impact factor: 12.079

6.  Atypical presentation of progressive supranuclear palsy.

Authors:  P H Davis; C Bergeron; D R McLachlan
Journal:  Ann Neurol       Date:  1985-04       Impact factor: 10.422

7.  The use of botulinum toxin in blepharospasm.

Authors:  N Shorr; S R Seiff; J Kopelman
Journal:  Am J Ophthalmol       Date:  1985-05-15       Impact factor: 5.258

8.  Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients.

Authors:  J Jankovic; J Ford
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

9.  Blepharospasm surgery. An anatomical approach.

Authors:  W N Gillum; R L Anderson
Journal:  Arch Ophthalmol       Date:  1981-06

10.  Ipsilateral blepharospasm and contralateral hemidystonia and parkinsonism in a patient with a unilateral rostral brainstem-thalamic lesion: structural and functional abnormalities studied with CT, MRI, and PET scanning.

Authors:  K L Leenders; R S Frackowiak; N Quinn; D Brooks; D Sumner; C D Marsden
Journal:  Mov Disord       Date:  1986       Impact factor: 10.338

View more
  1 in total

1.  Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm.

Authors:  A Berardelli; A Carta; F Stocchi; A Formica; A Agnoli; M Manfredi
Journal:  Ital J Neurol Sci       Date:  1990-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.